• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对比剂诱导急性肾损伤定义对临床结局的影响。

Impact of contrast-induced acute kidney injury definition on clinical outcomes.

机构信息

Cardiovascular Department, San Giovanni Battista Hospital, Turin, Italy.

出版信息

Am Heart J. 2011 May;161(5):963-71. doi: 10.1016/j.ahj.2011.02.004.

DOI:10.1016/j.ahj.2011.02.004
PMID:21570530
Abstract

BACKGROUND

Contrast-induced acute kidney injury (CIAKI) is a frequent complication after infusion of contrast media in patients undergoing percutaneous coronary intervention. A wide range of CIAKI rates occurs after intervention between 3% and 30%, depending on the definition. The aim of this study was to identify which methodology was more effective at recognizing patients at high risk for in-hospital and out-of-hospital adverse events.

METHODS AND RESULTS

Serum creatinine increases, after contrast agent infusion, were evaluated in 755 consecutive and unselected patients. Incidences of CIAKI diagnosed by 2 common definitions varied from 6.9% (creatinine increase of ≥0.5 mg/dL, CIAKI-0.5) to 15.9% (creatinine increase of ≥25%, CIAKI-25%). Significant differences appeared between the 2 definitions of sensitivity to predict renal failure according to receiver operating characteristic curve analysis (98% for CIAKI-0.5 and 62% for CIAKI-25%), using a cutoff value of postprocedural glomerular filtration rate of 60 mL/min. Both definitions of CIAKI were related to composite adverse events, but CIAKI-0.5 showed a stronger predicting value (odds ratio 2.875 vs 1.802, P = .036). In multivariate linear regression, only CIAKI-0.5 was a predictive variable of death (odds ratio 3.174, 95% CI 1.368-7.361).

CONCLUSIONS

An increase in serum creatinine of ≥0.5 mg/dL is more sensitive because it recognizes more selectively those patients with a higher risk of mortality and morbidity. Serum creatinine increases of ≥25% overestimate CIAKI by including many patients without postprocedural relevant deterioration of renal function and affected by a lower risk of adverse events at follow-up.

摘要

背景

对比剂诱导的急性肾损伤(CIAKI)是经皮冠状动脉介入治疗患者输注对比剂后的常见并发症。根据定义的不同,介入后 CIAKI 发生率在 3%至 30%之间变化很大。本研究旨在确定哪种方法更能有效地识别发生院内和院外不良事件的高危患者。

方法和结果

在 755 例连续和未选择的患者中评估了对比剂输注后血清肌酐的升高。用两种常见定义诊断 CIAKI 的发生率分别为 6.9%(肌酐升高≥0.5mg/dL,CIAKI-0.5)和 15.9%(肌酐升高≥25%,CIAKI-25%)。根据受试者工作特征曲线分析,两种 CIAKI 定义在预测肾功能衰竭的敏感性方面存在显著差异(CIAKI-0.5 的截断值为 98%,CIAKI-25%的截断值为 62%)。两种 CIAKI 定义均与复合不良事件相关,但 CIAKI-0.5 具有更强的预测价值(比值比 2.875 比 1.802,P =.036)。多元线性回归显示,只有 CIAKI-0.5 是死亡的预测变量(比值比 3.174,95%CI 1.368-7.361)。

结论

血清肌酐升高≥0.5mg/dL 更敏感,因为它更有选择性地识别那些死亡率和发病率更高的患者。血清肌酐升高≥25%通过包括许多肾功能无术后相关恶化且在随访中不良事件风险较低的患者,高估了 CIAKI。

相似文献

1
Impact of contrast-induced acute kidney injury definition on clinical outcomes.对比剂诱导急性肾损伤定义对临床结局的影响。
Am Heart J. 2011 May;161(5):963-71. doi: 10.1016/j.ahj.2011.02.004.
2
Contrast-induced kidney injury: how does it affect long-term cardiac mortality?对比剂诱导的肾损伤:它如何影响长期心脏死亡率?
J Cardiovasc Med (Hagerstown). 2017 Nov;18(11):908-915. doi: 10.2459/JCM.0000000000000543.
3
Contrast-induced acute kidney injury following coronary angiography: a cohort study of hospitalized patients with or without chronic kidney disease.冠状动脉造影术后对比剂诱导的急性肾损伤:一项伴或不伴慢性肾脏病的住院患者队列研究。
Nephrol Dial Transplant. 2013 Jun;28(6):1463-71. doi: 10.1093/ndt/gft082. Epub 2013 Apr 12.
4
[Contrast-induced acute kidney injury after primary percutaneous coronary interventions: Prevalence, predictive factors, and outcomes].[直接经皮冠状动脉介入治疗后对比剂诱导的急性肾损伤:患病率、预测因素及预后]
Ter Arkh. 2015;87(6):50-55. doi: 10.17116/terarkh201587650-55.
5
Short-Term High-Dose Vitamin E to Prevent Contrast Medium-Induced Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Elective Coronary Angiography: A Randomized Placebo-Controlled Trial.短期大剂量维生素E预防择期冠状动脉造影的慢性肾脏病患者造影剂诱导的急性肾损伤:一项随机安慰剂对照试验
J Am Heart Assoc. 2016 Mar 15;5(3):e002919. doi: 10.1161/JAHA.115.002919.
6
Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease.慢性肾脏病患者经皮冠状动脉介入治疗后对比剂诱导的急性肾损伤结局的预测因素
Am J Cardiol. 2014 Dec 15;114(12):1830-5. doi: 10.1016/j.amjcard.2014.09.022. Epub 2014 Sep 28.
7
Effect of renin-angiotensin-system blockers on contrast-medium-induced acute kidney injury after coronary angiography.肾素-血管紧张素系统阻滞剂对冠状动脉造影后造影剂诱导的急性肾损伤的影响。
Korean J Intern Med. 2014 Mar;29(2):203-9. doi: 10.3904/kjim.2014.29.2.203. Epub 2014 Feb 27.
8
AKIGUARD (Acute Kidney Injury GUARding Device) trial: in-hospital and one-year outcomes.AKIGUARD(急性肾损伤保护装置)试验:住院期间及一年的结果。
J Cardiovasc Med (Hagerstown). 2016 Jul;17(7):530-7. doi: 10.2459/JCM.0000000000000348.
9
Long-Term (3 Years) Prognosis of Contrast-Induced Acute Kidney Injury After Coronary Angiography.冠状动脉造影术后对比剂诱导的急性肾损伤的长期(3年)预后
Am J Cardiol. 2016 Jun 1;117(11):1741-6. doi: 10.1016/j.amjcard.2016.03.008. Epub 2016 Mar 23.
10
Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial.接受经皮冠状动脉介入治疗的稳定性或不稳定性冠状动脉疾病连续患者中,对比剂诱导的急性肾损伤的发生率、预后影响及最佳定义。来自全人群PRODIGY试验的见解。
Catheter Cardiovasc Interv. 2015 Jul;86(1):E19-27. doi: 10.1002/ccd.25822. Epub 2015 Feb 20.

引用本文的文献

1
Efficacy of the Renal-guard system in the prevention of contrast-induced nephropathy following cardiac interventions among patients with chronic kidney disease.肾脏保护系统在预防慢性肾病患者心脏介入术后对比剂肾病中的疗效。
Front Cardiovasc Med. 2025 Mar 3;12:1438076. doi: 10.3389/fcvm.2025.1438076. eCollection 2025.
2
Differential Incidence of Contrast-Associated Acute Kidney Injury: Comparing Intravenous and Intraarterial Contrast Administration.对比剂相关急性肾损伤的差异发生率:静脉内与动脉内对比剂给药的比较。
Curr Cardiol Rep. 2024 Aug;26(8):833-841. doi: 10.1007/s11886-024-02083-w. Epub 2024 Jul 16.
3
Impact of atorvastatin reload on the prevention of contrast-induced nephropathy in patients on chronic statin therapy: A prospective randomized trial.
阿托伐他汀再负荷对慢性他汀治疗患者预防造影剂肾病的影响:一项前瞻性随机试验。
PLoS One. 2023 May 8;18(5):e0270000. doi: 10.1371/journal.pone.0270000. eCollection 2023.
4
Incidence, predictors and clinical implications of new renal impairment following percutaneous coronary intervention.经皮冠状动脉介入治疗后新发肾功能不全的发生率、预测因素及其临床意义。
Open Heart. 2022 Oct;9(2). doi: 10.1136/openhrt-2021-001876.
5
Strategies for Renal Protection in Cardiovascular Interventions.心血管介入治疗中的肾脏保护策略
Korean Circ J. 2022 Jul;52(7):485-495. doi: 10.4070/kcj.2022.0093.
6
Contrast-Associated Acute Kidney Injury.造影剂相关急性肾损伤
J Clin Med. 2022 Apr 13;11(8):2167. doi: 10.3390/jcm11082167.
7
The Pathophysiology and the Management of Radiocontrast-Induced Nephropathy.放射性造影剂所致肾病的病理生理学与管理
Diagnostics (Basel). 2022 Jan 12;12(1):180. doi: 10.3390/diagnostics12010180.
8
A Comparison Between Two Definitions of Contrast-Associated Acute Kidney Injury for Long-Term Mortality in Elderly and Non-elderly Patients After Elective Percutaneous Coronary Intervention.选择性经皮冠状动脉介入治疗后老年和非老年患者中,两种对比剂相关性急性肾损伤定义对长期死亡率的比较
Front Cardiovasc Med. 2021 Sep 27;8:720857. doi: 10.3389/fcvm.2021.720857. eCollection 2021.
9
Timing of AKI after urgent percutaneous coronary intervention and clinical outcomes: a high-dimensional propensity score analysis.急性肾损伤在紧急经皮冠状动脉介入治疗后的时间与临床结局:高维倾向评分分析。
BMC Nephrol. 2021 Sep 6;22(1):300. doi: 10.1186/s12882-021-02513-9.
10
Association of Early and Late Contrast-Associated Acute Kidney Injury and Long-Term Mortality in Patients Undergoing Coronary Angiography.对比剂相关急性肾损伤的早期和晚期与冠状动脉造影术后患者长期死亡率的关系。
J Interv Cardiol. 2021 Mar 8;2021:6641887. doi: 10.1155/2021/6641887. eCollection 2021.